Bioprinting drug delivery

Bioprinting drug delivery systems

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)

This article needs attention from an expert in Medicine. Please add a reason or a talk parameter to this template to explain the issue with the article. WikiProject Medicine may be able to help recruit an expert. (April 2023)

|

This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (May 2023)

|

This article may be too technical for most readers to understand. Please help improve it to make it understandable to non-experts, without removing the technical details. (June 2023) (Learn how and when to remove this message)

|

(Learn how and when to remove this message)

Bioprinting drug delivery is a method for producing drug delivery vehicles. It uses 3D printing of biomaterials. Such vehicles are biocompatible, tissue-specific hydrogels or implantable devices. 3D bioprinting prints cells and biological molecules to form tissues, organs, or biological materials in a scaffold-free manner that mimics living human tissue. The technique allows targeted disease treatments with scalable and complex geometry.

This technique was first developed in the 1950s as patients with incurable diseases sought organ transplantations beyond those available from donors. Organ transplantation showed limitations with immune responses and organ rejection.[1]

Techniques that have been studied include bioprinting hydrogels with various bio-ink (cell-laden microgel) materials and bioprinting implantable devices that mimic specific tissues or biological functions. Applications include promoting wound healing by delivering antibiotics, anti-inflammatory treatments, or drugs that promote cell differentiation and cell proliferation, providing anticancer treatments directly to tumors, and promoting/inhibiting angiogenesis and vascularization to treat cancer, arterial diseases, heart diseases, and arthritis. In addition, implants can be printed in unique shapes and forms to deliver drugs directly to targeted tissues. One approach adds a fourth dimension, which allows the materials to conform, by folding/unfolding, to release drugs in a more controlled manner. Bioprinting allows for biocompatible, biodegradable, universal, and personalized delivery vehicles.

## Methods

[edit]

Layer-by-layer printing of biochemicals and living cells requires precise placement and viable materials. The basic technology of a bioprinter starts with data taken from computer-assisted design (CAD) or a similar program, uses motion control systems to control the X/Y/Z axis direction drive mechanisms along with a material control system for the bio-ink printhead, and deposits material into a 3D construct.[2] Bioprinting can be done by material jetting, material extrusion, or vat polymerization.[2][3]

### Jetting

[edit]

Material jetting, sometimes referred to as fused deposition modeling (FDM), is a method that involves depositing cells using piezoelectric/thermal ink-jetting, acoustic wave jetting, electrohydrodynamic jetting, or laser-induced forward transfer (LIFT).[3] Piezoelectric/thermal ink-jetting uses the same non-contact process as desktop inkjet printers by pressuring material into a nozzle that expels droplets. Acoustic wave jetting uses acoustic radiation force to produce droplets; electrohydrodynamic jetting uses electric voltage to form droplets; and LIFT is replaces nozzles with a laser and generates a high-pressure bubble that propels droplets.[3] These methods provide precise placement of the bioink and enable scaffold-free bioprinting.

### Extrusion

[edit]

Another method of bioprinting is extrusion. This is a mechanical method that uses motors to drive a piston. Extrusion is based on the rate of the motor's displacement, where the difference between the piston-driven pressure and ambient pressure drives the material through an angular turn of a rotary screw.[3]

### Vat polymerization

[edit]

Vat polymerization printing (VPP) uses a cell-hydrogel suspension. The constructs are formed layer-by-layer through laser curing in stereolithography (SLA) or UV digital light processing (DLP) into the vat of a photopolymer using a micromirror device.[3]

## Hydrogels

[edit]

Hydrogels are three-dimensional polymeric networks that can maintain their structure while absorbing large amounts of water or biological fluids. Hydrogels can be made of many different synthetic polymers or natural polysaccharides. These have been widely studied due to their similarities to the human extracellular matrix (ECM) and their ability to encapsulate drugs. They are mainly printed using jetting and extrusion.[3]

### Alginates

[edit]

A common polysaccharide used in biomedical hydrogel applications is alginate, a naturally occurring polyanionic copolymer.[1] The structure and high water absorption of alginate provides a tissue environment that closely mimics human soft tissue. In addition, it is an ideal candidate for biomedical applications due to its natural biodegradability and biocompatibility. This hydrogel leverages the delivery of drugs, protects drugs with encapsulation, and allows for tunable drug release and degradability

To construct alginate hydrogels, a series of negatively and positively charged polyelectrolytes are assembled layer-by-layer. Alginate is used as the matrix in bio-ink that is extruded from the bioprinter's syringe with increasing shear, resulting in a tough hydrogel with low viscosity. Depending on the surrounding medium, alginate has the potential to form two different types of gels. Low-pH alginate shrinks and produces a viscous acidic gel, holding onto encapsulated drugs. Once the pH increases, such as inside an intestinal tract, alginate turns into a viscose gel that allows drug dissolution and release. This process allows for a controlled and sustained release to specific tissues.

One 2018 study used alginate-based hydrogels combined with the growth factor platelet-rich plasma (PRP) to develop a bio-ink with personalized biological factors. The plasms was extracted from specific patients, then mixed with the alginate solution. The solution was coated with calcium chloride agarose gel. The result was a hydrogel disk that had decreased the risk of immune responses from the patient. The disk showed potential for promoting mesenchymal stem cells and endothelial cells in tissue healing. The study reported that PRP and alginate hydrogel bio-ink could be used by any bioprinter to produce personalized drug delivery therapies.[4]

The hydrogel can be loaded with any drug, and target any tissue. The low toxicity and controllable factors of alginate make it a suitable candidate for hydrogel incorporation. Alginate hydrogels have been used to deliver bortezomib, an anticancer drug, tetracycline hydrochloride and silver sulfadiazine, which are hydrophobic antibiotics, and simvastatin, which promotes local stem cell differentiation.[5]

### Peptides

[edit]

Another bio-ink is low molecular weight self-assembling peptide-based materials. Peptide-based hydrogels are candidates for bio-inks since they resemble the ECM. In addition, their mechanical strength and stiffness of up to 40 kPa allow for strong and rigid hydrogels.[6]

A 2019 study used the "helical coiling of micelles induced by disulfide crosslinking in a lyotropic peptide liquid crystal" to produce a printable hydrogel. They reported that the tripeptide self-assembled into a viscous solution of aligned micelles at high pH values that could be transformed into a self-supporting hydrogel when the cross-linking of the sulfhydryl group of the side chain peptides increased the storage modulus of the solution.[7]

These self-assembling peptides provide beneficial organization and strength. In addition, their resemblance to the native cellular microenvironment and tunable mechanical strength allow them to support the proliferation of human stem cells. Using self-assembling peptides to print hydrogels provides drug delivery vehicles that represent the ECM and potentially differentiate primary cells into organotypic structures and deliver antimicrobial, anti-inflammatory, anticancer, and wound healing drugs.[6][7] Specifically, hydrogels made of such peptides have been studied to encapsulate chemotherapy drugs that can disassemble and release the loaded drug under the stimulation of tumor environments, providing an alternative to typical chemotherapy that inevitably damages healthy cells, while killing cancer cells.[8]

### Protein

[edit]

Common protein-based bio-inks include collagen, keratin, gelatin, and silk. These proteins are advantageous since they are in the ECM and display good cytocompatibility, biocompatibility, and biodegradability. They are all derived from natural sources, are isolated with different methods, and have various advantages and disadvantages. Collagen is typically printed using extrusion or SLA and provides good structural responses and esion for cells.[9][10][11] Silk is printed using digital light processing, and provides strength and robustness. One disadvantage of silk is its potential to conform in response to high shear forces.[9][10][11][12] Gelatin is printed using extrusion and provides good cellular affinity, however, its covalent crosslinking-based stabilization requires chemical reactions that are not cytocompatible.[9][10][11][12][13] Overall, protein-based bio-inks are abundant, inexpensive, biocompatible, and biodegradable, and are in common use for 3D bioprinting. Advantages of protein-based bio-inks over synthetic bio-inks include their similarity to human host tissue and their ability to match their degradation rate with the regeneration of host tissue.

Comparisons[9][10][11][12][13] Protein | Source(s) | Printing Method | Advantages | Disadvantages

|
|
|
|

Silk | Silkworm | Digital light processing | High strength and robustness. High solubility and printing fidelity. | Conforms at high shear forces, so not suitable for printing at low concentrations.
Keratin | Spider, sheep wool, and human hair | Extrusion | High strength and fidelity. Good cell adherence and viability. | Can be difficult to achieve and have varying properties in humid air.
Gelatin | Gelatin | Extrusion | Good cellular affinity and proliferation. | Requires non-cytocompatible chemical reactions and has a risk of degradation at high temperatures.
Collagen | Porcine and fish | Extrusion or SLA | Good structural responses and cell adhesion. High porosity and tensile strength. | Possible lack of biocompatibility and immunogenicity concerns.

#### Applications

[edit]

Multiple protein applications use bio-inks for 3D printing. A 2014 study bioprinted cell-laden methacrylated gelatin (GelMA) hydrogels at concentrations ranging from 7 to 15% with varying cell densities.[14] The study used "direct-write bioprinting of cell-laden photolabile ECM-derived hydrogels".[14] They reported a direct correlation between printability and hydrogel mechanical properties. A commercially available bioprinter dispensed the GelMA hydrogel fibers using digital light processing since GelMA is photosensitive. The hydrogels provided cell viability for at least eight days.[14]

Other research includes gelatin-sulfonated skin composite tissue to deliver cells to open wounds by seeding matrices.[15][16] Doing this helps wounds to heal faster and more efficiently. Gelatin hydrogels have successfully delivered fluorescein, a hydrophobic molecule, and microRNA to promote osteogenic cell differentiation.[13] Silk has successfully delivered aspirin, an anti-inflammatory drug that aids in wound dressing, and gentamicin, an antibiotic that also aids in wound dressing.[13]

### Nanocellulose

[edit]

Another bio-ink that has been successful in producing drug delivery systems via bioprinting is cellulosic nanomaterials. Cellulose-based bio-inks are accessible, inexpensive, biodegradable, biocompatible, and stiff. A polysaccharide is obtained from the biosynthesis of plants and bacteria. It is extracted from raw materials with mechanical shearing actions and biological treatments, such as hydrolysis, resulting in highly structured nanofibrils. Cellulose materials are defined by their high viscosity and shear-thinning behavior.[17]

One 2015 study used nanocellulose bio-inks as wound dressings. Extrusion produced porous structures with ionic calcium chloride cross-linking. These porous hydrogels were reported to support bacterial growth and incorporate and release antimicrobial drugs. These structures provide strong, moist environments that are ideal for delivering drugs to tissues that require wound healing aid.[18]

Nanocellulose cross-linked with calcium chloride printed on a nanocellulose hydrogel film.

## Non-hydrogel implants

[edit]

Non-hydrogel delivery systems implants are printed in the same manner as hydrogels. A 2022 study used SLA 3D printing to produce an implant to deliver drugs to the ear. 0.5% levofloxacin was added to a flexible resin. Mechanical and in vitro tests measured levofloxacin release. The results showed no interaction between the resin and the drug, the resistance of the implant without compromise, and high antimicrobial activity. Antibiotics were delivered directly to the inner ear to address infection.[19]

Researchers studied a printed bladder device for intravesical drug delivery.[20] Intravesical instillation provides an alternative to oral medication and delivers high drug concentrations to specific sites. Studies reported the use indwelling bladder devices with an elastic polymer bio-ink to deliver lidocaine hydrochloride directly to the target site.

One study deposited perfusable vascular structures with a cell-responsive bio-ink that consisted of GelMA, sodium alginate, and poly(ethylene glycol)-tetra-acrylate (PEGTA).[21] The study reported that this supported the spreading and proliferation of encapsulated endothelial and stem cells, leading to the formation of perfusable vessels. These may lead to the application of vascularized tissue constructs in organ transplantation and repair. Bioprinting vascular structures may lead to treatments for cancer, arterial disease, heart disease, and arthritis by regulating vascularization and angiogenesis.

### Nanocellulose

[edit]

Cellulose nanofibrils have been used as a bio-ink for non-hydrogel applications. A 2017 study evaluated the use of bioprinting cellulose as drug-loaded implants. Researchers used FDM to evaluate drug release behavior. Fluorescent dye quinine was used to visualize the distribution of drugs in the implants. Quinine filaments were loaded into bio-printed cellulose implants and then incubated to observe their drug-release behaviors. The study reported showed that around 5% of the quinine was released from the cellulose implant over 100 days. Using cellulose nanofibrils might provide implants with customizable shapes and controlled release of loaded drugs via FDM.[22]

## 4D bioprinting

[edit]

One study added a fourth dimension to the devices, which allows printed objects to change their shapes and functions as external factors are applied, broadening the range of biomedical applications as cellular self-organization becomes possible.[23] This technique allows for more advanced control of drug release. Studies have reported results in the use of responsive materials and bio-inks. Responsive materials can reshape in response to stimuli, such as transforming via self-folding, assembling, and disassembling. Certain bio-inks have been reported to undergo maturation with cellular coating, self-organization, and matrix deposition.

### Applications

[edit]

Examples include a self-folding hydrogel in vitro model for ductal carcinoma.[24] The study attempted to create a self-folding curved hydrogel microstructure to mimic the geometry of ducts and acini within mammary glands. The researchers used microstructures composed of poly(ethylene glycol)-diacrylate (PEGDA) and copolymerized the PEGDA to synthesize microstructures with increased cell adherence. Curved and tubular structures were fabricated via bioprinting, and the proliferation of cells on the outer surface, along with encapsulation of cells on the inner surface, was observed.

4D printing with thermally actuating hydrogels was reported to be relatively fast and reversible with skeletal muscle-like linear actuation in tough hydrogel materials that control the flow of water.[25] Other examples include the usage of water absorption[26] and thermal shape memory[27] to demonstrate shape change. A 2015 study considered a 4D-printed capsule system that could release drugs on-demand at specific locations with a core-shell hydrogel.[28] A 2014 study evaluated thermo-responsive poly(propylene fumarate) (PPF)-based system that released drugs in a controlled manner for treating the gastrointestinal tract.[29]

## References

[edit]

1. ^ a b Abasalizadeh, Moghaddam (2020). "Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting". Journal of Biological Engineering. 14: 8. doi:10.1186/s13036-020-0227-7. PMC 7069202. PMID 32190110. S2CID 255987816.
2. ^ a b Li, J (2016). "Recent advances in bioprinting techniques: approaches, applications, and prospects". Journal of Translational Medicine. 14: 271. doi:10.1186/s12967-016-1028-0. PMC 5028995. PMID 27645770.
3. ^ a b c d e f Lee, J.M.; Sing, S.L.; Zhou, M; Yeong, W.Y. (2018). "3D bioprinting processes: A perspective on classification and terminology". International Journal of Bioprinting. 4 (2): 151. doi:10.18063/ijb.v4i2.151. PMC 7582007. PMID 33102923.
4. ^ Faramarzi, N (2018). "Patient-specific bioinks for 3D bioprinting of tissue engineering scaffolds". Advanced Healthcare Materials. 7 (11): e1701347. doi:10.1002/adhm.201701347. hdl:1721.1/140759. PMC 6422175. PMID 29663706.
5. ^ Vigata, M; Hutmacher, D; Bock, N (2020). "Hydrogels as drug delivery systems: A review of current characterization and evaluation techniques". Pharmaceutics. 12 (12): 1188. doi:10.3390/pharmaceutics12121188. PMC 7762425. PMID 33297493.
6. ^ a b Das, A.K.; Gavel, P.K. (2020). "Soft Matter". 16 (44): 10065–10095\. doi:10.1039/D0SM01136C. PMID 33073836. S2CID 224781478. Retrieved 8 April 2023.10065-10095&rft.date=2020&rft_id=https://api.semanticscholar.org/CorpusID:224781478#id-name=S2CID&rft_id=info:pmid/33073836&rft_id=info:doi/10.1039/D0SM01136C&rft.aulast=Das&rft.aufirst=A.K.&rft.au=Gavel,+P.K.&rft_id=https://pubs.rsc.org/en/content/articlelanding/2020/sm/d0sm01136c&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988"> `{{cite journal}}`: Cite journal requires `|journal=` (help)
7. ^ a b Yang, X; Wang, Y; Qi, W; Xing, R; Yang, X; Xing, Q; Su, R; He, S (2019). "J. Mater. Chem. B". Journal of Materials Chemistry B. 7 (18): 2981–2988\. doi:10.1039/C8TB03121E. S2CID 109858112. Retrieved 10 April 2023.2981-2988&rft.date=2019&rft_id=info:doi/10.1039/C8TB03121E&rft_id=https://api.semanticscholar.org/CorpusID:109858112#id-name=S2CID&rft.aulast=Yang&rft.aufirst=X&rft.au=Wang,+Y&rft.au=Qi,+W&rft.au=Xing,+R&rft.au=Yang,+X&rft.au=Xing,+Q&rft.au=Su,+R&rft.au=He,+S&rft_id=https://pubs.rsc.org/en/content/articlelanding/2019/tb/c8tb03121e&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
8. ^ Gao, Y; Zhang, C; Chang, J; Yang, C; Liu, J; Fan, S; Ren, C (2019). "Biomater. Sci". Biomaterials Science. 7 (4): 1477–1485\. doi:10.1039/C8BM01422A. PMID 30672520. S2CID 58948074. Retrieved 8 April 2023.1477-1485&rft.date=2019&rft_id=https://api.semanticscholar.org/CorpusID:58948074#id-name=S2CID&rft_id=info:pmid/30672520&rft_id=info:doi/10.1039/C8BM01422A&rft.aulast=Gao&rft.aufirst=Y&rft.au=Zhang,+C&rft.au=Chang,+J&rft.au=Yang,+C&rft.au=Liu,+J&rft.au=Fan,+S&rft.au=Ren,+C&rft_id=https://pubs.rsc.org/en/content/articlelanding/2019/bm/c8bm01422a&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
9. ^ a b c d Hong, H; Seo, Y.B.; Kim, D.Y.; Lee, J.S.; Lee, Y.J; Lee, H; Ajiteru, O; Sultan, M.T.; Lee, O.J.; Kim, S.H. (2020). "Digital light processing 3D printed silk fibroin hydrogel for cartilage tissue engineering". Biomaterials. 232: 119679. doi:10.1016/j.biomaterials.2019.119679. PMID 31865191. S2CID 209447166. Retrieved 9 April 2023.
10. ^ a b c d Cao, Y; Lee, B.H.; Irvine, S.A.; Wong, Y.S.; Bianco, H; Venkatraman, S (2020). "Inclusion of Cross-Linked Elastin in Gelatin/PEG Hydrogels Favourably Influences Fibroblast Phenotype". Polymers. 12 (3): 670. doi:10.3390/polym12030670. PMC 7183321. PMID 32192137.
11. ^ a b c d Lee, H.J.; Kim, Y.B.; Ahn, S.H.; Lee, J.S.; Jang, C.H.; Yoon, H; Chun, W; Kim, G.H. (2015). "New Approach for Fabricating Collagen/ECM-Based Bioinks Using Preosteoblasts and Human Adipose Stem Cells". Advanced Healthcare Materials. 4 (9): 1359–1368\. doi:10.1002/adhm.201500193. PMID 25874573. S2CID 24625469. Retrieved 9 April 2023.1359-1368&rft.date=2015&rft_id=https://api.semanticscholar.org/CorpusID:24625469#id-name=S2CID&rft_id=info:pmid/25874573&rft_id=info:doi/10.1002/adhm.201500193&rft.aulast=Lee&rft.aufirst=H.J.&rft.au=Kim,+Y.B.&rft.au=Ahn,+S.H.&rft.au=Lee,+J.S.&rft.au=Jang,+C.H.&rft.au=Yoon,+H&rft.au=Chun,+W&rft.au=Kim,+G.H.&rft_id=https://onlinelibrary.wiley.com/doi/10.1002/adhm.201500193&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
12. ^ a b c Hong, N (2018). "3D bioprinting and its in vivo applications". Journal of Biomedical Materials Research Part B: Applied Biomaterials. 106 (1): 444–459\. doi:10.1002/jbm.b.33826. PMID 28106947.444-459&rft.date=2018&rft_id=info:doi/10.1002/jbm.b.33826&rft_id=info:pmid/28106947&rft.aulast=Hong&rft.aufirst=N&rft_id=https://doi.org/10.1002%2Fjbm.b.33826&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
13. ^ a b c d Mirzaei, M; Okoro, O.V.; Nie, L; Petri, D.F.S.; Shavandi, A (2021). "Protein-based 3D bio fabrication of Biomaterials". Bioengineering. 8 (4): 48. doi:10.3390/bioengineering8040048. PMC 8073780. PMID 33923425.
14. ^ a b c Bertassoni, L.E.; Cardoso, J.C.; Manoharon, V; Cristino, A.L.; Bhise, N.S.; Araujo, W; Zorlutuna, P; Vrana, N.E.; Ghaemmaghami, A.M.; Dokmeci, M.R. (2014). "Direct-write bioprinting of cell-laden methacrylated gelatin hydrogels". Biofabrication. 6 (2): 024105. Bibcode:2014BioFa...6b4105B. doi:10.1088/1758-5082/6/2/024105. PMC 4040163. PMID 24695367. Retrieved 10 April 2023.
15. ^ Du, H; Taylor, H.S. (2010). "Stem Cells and reproduction". Current Opinion in Obstetrics & Gynecology. 22 (3): 235–241\. doi:10.1097/GCO.0b013e328338c152. PMC 3107846. PMID 20305558.235-241&rft.date=2010&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107846#id-name=PMC&rft_id=info:pmid/20305558&rft_id=info:doi/10.1097/GCO.0b013e328338c152&rft.aulast=Du&rft.aufirst=H&rft.au=Taylor,+H.S.&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107846&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
16. ^ Albanna, M; Binder, K.W.; Murphy, S.V.; Kim, J; Qasem, S.A.; Zhao, W; Tan, J; El-Amin, I.B.; Dice, D.D.; Marco, J (2019). "In Situ Bioprinting of Autologous Skin Cells Accelerates Wound Healing of Extensive Excisional Full-Thickness Wounds". Scientific Reports. 9 (1): 1856. Bibcode:2019NatSR...9.1856A. doi:10.1038/s41598-018-38366-w. PMC 6372693. PMID 30755653.
17. ^ Piras, C; Fernández-Prieto, S; Borggraeve, W.M.D (2017). "Nanocellulosic materials as bio-inks for 3D bioprinting". Biomaterials Science. 5 (10): 1988–1992\. doi:10.1039/C7BM00510E. PMID 28829453. Retrieved 9 April 2023.1988-1992&rft.date=2017&rft_id=info:doi/10.1039/C7BM00510E&rft_id=info:pmid/28829453&rft.aulast=Piras&rft.aufirst=C&rft.au=Fernández-Prieto,+S&rft.au=Borggraeve,+W.M.D&rft_id=https://pubs.rsc.org/en/content/articlelanding/2017/bm/c7bm00510e/unauth#!divCitation&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
18. ^ Rees, A; Powell, L.C.; Chinga-Carrasco, G; Gethin, D.T.; Syverud, K; Hill, K.E.; Thomas, D.W. (2015). "3D Bioprinting of Carboxymethylated-Periodate Oxidized Nanocellulose Constructs for Wound Dressing Applications". BioMed Research International. 2015: e925757. doi:10.1155/2015/925757. PMC 4452270. PMID 26090461.
19. ^ Triacca, A; Pitzanti, G; Matthew, E; Conti, B; Dorati, R; Lamprou, D.A. (2022). "Stereolithography 3D printed implants: A preliminary investigation as potential local drug delivery systems to the ear". International Journal of Pharmaceutics. 616: 121529. doi:10.1016/j.ijpharm.2022.121529. PMID 35114311. S2CID 246512205.
20. ^ Goyanes, A; Xu, X; Trenfield, S.J.; Diaz-Gomez, L; Alvarez-Lorenzo, C; Gaisford, S; Basit, A.W. (2021). "Stereolithography (SLA) 3D printing of a bladder device for intravesical drug delivery". Materials Science and Engineering: C. 120: 111773. doi:10.1016/j.msec.2020.111773. PMID 33545904. S2CID 230557189.
21. ^ Jia, W; Gungor-Ozkerim, P.S.; Zhang, Y.S.; Yue, K; Zhu, K; Liu, W; Pi, Q; Byambaa, B; Dokmeci, M.R.; Shin, S.R.; Khademhosseini, A (2016). "Direct 3D bioprinting of perfusable vascular constructs using a blend bio-ink". Biomaterials. 106: 58–68\. doi:10.1016/j.biomaterials.2016.07.038. PMC 5300870. PMID 27552316.58-68&rft.date=2016&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300870#id-name=PMC&rft_id=info:pmid/27552316&rft_id=info:doi/10.1016/j.biomaterials.2016.07.038&rft.aulast=Jia&rft.aufirst=W&rft.au=Gungor-Ozkerim,+P.S.&rft.au=Zhang,+Y.S.&rft.au=Yue,+K&rft.au=Zhu,+K&rft.au=Liu,+W&rft.au=Pi,+Q&rft.au=Byambaa,+B&rft.au=Dokmeci,+M.R.&rft.au=Shin,+S.R.&rft.au=Khademhosseini,+A&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300870&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
22. ^ Kempin, W; Franz, C; Koster, L.C.; Schneider, F; Bogdahn, M; Weitschies, W; Seidlitz, A (2017). "Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants". European Journal of Pharmaceutics and Biopharmaceutics. 115: 84–93\. doi:10.1016/j.ejpb.2017.02.014. PMID 28232106. S2CID 3402723. Retrieved 9 April 2023.84-93&rft.date=2017&rft_id=https://api.semanticscholar.org/CorpusID:3402723#id-name=S2CID&rft_id=info:pmid/28232106&rft_id=info:doi/10.1016/j.ejpb.2017.02.014&rft.aulast=Kempin&rft.aufirst=W&rft.au=Franz,+C&rft.au=Koster,+L.C.&rft.au=Schneider,+F&rft.au=Bogdahn,+M&rft.au=Weitschies,+W&rft.au=Seidlitz,+A&rft_id=https://pubmed.ncbi.nlm.nih.gov/28232106/&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
23. ^ Gao, B; Yang, Q; Zhao, X; Jin, G; Ma, Y; Xu, F (2016). "4D bioprinting for biomedical applications". Trends in Biotechnology. 34 (9): 746–756\. doi:10.1016/j.tibtech.2016.03.004. PMID 27056447. S2CID 3594292. Retrieved 10 April 2023.746-756&rft.date=2016&rft_id=https://api.semanticscholar.org/CorpusID:3594292#id-name=S2CID&rft_id=info:pmid/27056447&rft_id=info:doi/10.1016/j.tibtech.2016.03.004&rft.aulast=Gao&rft.aufirst=B&rft.au=Yang,+Q&rft.au=Zhao,+X&rft.au=Jin,+G&rft.au=Ma,+Y&rft.au=Xu,+F&rft_id=https://www.sciencedirect.com/science/article/pii/S0167779916000664&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
24. ^ Kwag, Hye Rin; Serbo, Janna; Korangath, Preethi; Sukumar, Saraswati; Romer, Lewis; Gracias, David (2016). "A Self-Folding Hydrogel In Vitro Model for Ductal Carcinoma". Tissue Engineering Part C: Methods. 22 (4): 398–407\. doi:10.1089/ten.TEC.2015.0442. PMC 4827285. PMID 26831041.398-407&rft.date=2016&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827285#id-name=PMC&rft_id=info:pmid/26831041&rft_id=info:doi/10.1089/ten.TEC.2015.0442&rft.aulast=Kwag&rft.aufirst=Hye+Rin&rft.au=Serbo,+Janna&rft.au=Korangath,+Preethi&rft.au=Sukumar,+Saraswati&rft.au=Romer,+Lewis&rft.au=Gracias,+David&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827285&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
25. ^ Bakarich, SE; Gorkin, R; Panhuis, M; Spinks, GM (2015). "4D printing with mechanically robust, thermally actuating hydrogels". Macromolecular Rapid Communications. 36 (12): 1211–1217\. doi:10.1002/marc.201500079. PMID 25864515.1211-1217&rft.date=2015&rft_id=info:doi/10.1002/marc.201500079&rft_id=info:pmid/25864515&rft.aulast=Bakarich&rft.aufirst=SE&rft.au=Gorkin,+R&rft.au=Panhuis,+M&rft.au=Spinks,+GM&rft_id=https://doi.org/10.1002%2Fmarc.201500079&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
26. ^ Tibbits, S (2014). "4D Printing: Multi-Material Shape Change". Architectural Design. 84: 116–121\. doi:10.1002/ad.1710. Retrieved 10 April 2023.116-121&rft.date=2014&rft_id=info:doi/10.1002/ad.1710&rft.aulast=Tibbits&rft.aufirst=S&rft_id=https://onlinelibrary.wiley.com/doi/abs/10.1002/ad.1710&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
27. ^ Ge, Q; Qi, H.J.; Dunn, M.L. (2013). "Active materials by four-dimension printing". Applied Physics Letters. 103 (13): 131901. Bibcode:2013ApPhL.103m1901G. doi:10.1063/1.4819837. S2CID 120595002.
28. ^ Gupta, M. K.; Meng, F.; Johnson, B. N.; Kong, Y. L.; Tian, L.; Yeh, Y. W.; Masters, N.; Singamaneni, S.; McAlpine, M. C. (June 4, 2015). "Nano Lett". Nano Letters. 15 (8): 5321–5329\. doi:10.1021/acs.nanolett.5b01688. PMC 4536147. PMID 26042472. Retrieved 10 April 2023.5321-5329&rft.date=2015-06-04&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536147#id-name=PMC&rft_id=info:pmid/26042472&rft_id=info:doi/10.1021/acs.nanolett.5b01688&rft.aulast=Gupta&rft.aufirst=M.+K.&rft.au=Meng,+F.&rft.au=Johnson,+B.+N.&rft.au=Kong,+Y.+L.&rft.au=Tian,+L.&rft.au=Yeh,+Y.+W.&rft.au=Masters,+N.&rft.au=Singamaneni,+S.&rft.au=McAlpine,+M.+C.&rft_id=https://doi.org/10.1021/acs.nanolett.5b01688&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">
29. ^ Malachowski, K; Breger, J; Kwag, H.R.; Wang, M.O.; Fisher, J.P.; Selaru, F.M.; Gracais, D.H. (2014). "Stimuli-Responsive Theragrippers for Chemomechanical Controlled Release". Angewandte Chemie International Edition. 53 (31): 8045–8049\. doi:10.1002/anie.201311047. PMC 4315180. PMID 24634136.8045-8049&rft.date=2014&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315180#id-name=PMC&rft_id=info:pmid/24634136&rft_id=info:doi/10.1002/anie.201311047&rft.aulast=Malachowski&rft.aufirst=K&rft.au=Breger,+J&rft.au=Kwag,+H.R.&rft.au=Wang,+M.O.&rft.au=Fisher,+J.P.&rft.au=Selaru,+F.M.&rft.au=Gracais,+D.H.&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315180&rfr_id=info:sid/en.wikipedia.org:Bioprinting+drug+delivery" class="Z3988">